Literature DB >> 16696478

Generalized five-dimensional dynamic and spectral factor analysis.

Georges El Fakhri1, Arkadiusz Sitek, Robert E Zimmerman, Jinsong Ouyang.   

Abstract

We have generalized the spectral factor analysis and the factor analysis of dynamic sequences (FADS) in SPECT imaging to a five-dimensional general factor analysis model (5D-GFA), where the five dimensions are the three spatial dimensions, photon energy, and time. The generalized model yields a significant advantage in terms of the ratio of the number of equations to that of unknowns in the factor analysis problem in dynamic SPECT studies. We solved the 5D model using a least-squares approach. In addition to the traditional non-negativity constraints, we constrained the solution using a priori knowledge of both time and energy, assuming that primary factors (spectra) are Gaussian-shaped with full-width at half-maximum equal to gamma camera energy resolution. 5D-GFA was validated in a simultaneous pre-/post-synaptic dual isotope dynamic phantom study where 99mTc and 123I activities were used to model early Parkinson disease studies. 5D-GFA was also applied to simultaneous perfusion/dopamine transporter (DAT) dynamic SPECT in rhesus monkeys. In the striatal phantom, 5D-GFA yielded significantly more accurate and precise estimates of both primary 99mTc (bias=6.4 % +/- 4.3 %) and 1231 (-1.7% +/- 6.9%) time activity curves (TAC) compared to conventional FADS (biases = 15.5% +/- 10.6% in 99mTc and 8.3% +/- 12.7% in 123I, p < 0.05). Our technique was also validated in two primate dynamic dual isotope perfusion/DAT transporter studies. Biases of 99mTc-HMPAO and 123I-DAT activity estimates with respect to estimates obtained in the presence of only one radionuclide (sequential imaging) were significantly lower with 5D-GFA (9.4% +/- 4.3% for 99mTc-HMPAO and 8.7% +/-4.1% for 123I-DAT) compared to biases greater than 15% for volumes of interest (VOI) over the reconstructed volumes (p < 0.05). 5D-GFA is a novel and promising approach in dynamic SPECT imaging that can also be used in other modalities. It allows accurate and precise dynamic analysis while compensating for Compton scatter and cross-talk.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16696478     DOI: 10.1118/1.2179168

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  8 in total

Review 1.  Future directions of myocardial fatty acid imaging.

Authors:  Christopher J Pastore; John W Babich; James E Udelson
Journal:  J Nucl Cardiol       Date:  2007 May-Jun       Impact factor: 5.952

2.  Comparison of simultaneous and sequential SPECT imaging for discrimination tasks in assessment of cardiac defects.

Authors:  C M Trott; J Ouyang; G El Fakhri
Journal:  Phys Med Biol       Date:  2010-11-03       Impact factor: 3.609

3.  Ready for prime time? Dual tracer PET and SPECT imaging.

Authors:  Georges El Fakhri
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-10-15

4.  Single-scan rest∕stress imaging (18)F-labeled flow tracers.

Authors:  Nathaniel Alpert; Yu-Hua Dean Fang; Georges El Fakhri
Journal:  Med Phys       Date:  2012-11       Impact factor: 4.071

5.  A Bayesian spatial temporal mixtures approach to kinetic parametric images in dynamic positron emission tomography.

Authors:  W Zhu; J Ouyang; Y Rakvongthai; N J Guehl; D W Wooten; G El Fakhri; M D Normandin; Y Fan
Journal:  Med Phys       Date:  2016-03       Impact factor: 4.071

Review 6.  Assessment of myocardial perfusion and function with PET and PET/CT.

Authors:  Mouaz H Al-Mallah; Arkadiusz Sitek; Stephen C Moore; Marcelo Di Carli; Sharmila Dorbala
Journal:  J Nucl Cardiol       Date:  2010-06       Impact factor: 5.952

7.  Single-input-dual-output modeling of image-based input function estimation.

Authors:  Yi Su; Kooresh I Shoghi
Journal:  Mol Imaging Biol       Date:  2009-12-01       Impact factor: 3.488

8.  Dual-tracer PET using generalized factor analysis of dynamic sequences.

Authors:  Georges El Fakhri; Cathryn M Trott; Arkadiusz Sitek; Ali Bonab; Nathaniel M Alpert
Journal:  Mol Imaging Biol       Date:  2013-12       Impact factor: 3.488

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.